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A case of moyamoya syndrome and spherocytosis with concurrent interstitial lung disease who underwent laparoscopic
splenectomyisbeingreported.Atheoryregardingtheircoexistenceisbeingforwardedtogetherwiththeiranestheticmanagement.
According to our search, this is the fourth case of moyamoya syndrome and the ﬁrst case with an associated interstitial lung disease
in a 10-year-old child.
1.Introduction
The disease moyamoya evolves from the Japanese word moya
meaning haziness resembling an exhaled cigarette smoke
puﬀy angiographic appearance of the collateral cerebral vas-
culature distant to the stenotic and occluded prominent ves-
sels around the circle of Willis [1], ﬁrst described in the liter-
ature by Suzuk and Takaku [2].
To our knowledge, so far, only three pediatric cases of
moyamoya syndrome have been reported. Owing to the pau-
city of the literature regarding an association of moyamoya
disease and hereditary spherocytosis, we are reporting ano-
ther case of moyamoya syndrome with hereditary sphero-
cytosis causing splenomegaly and an interstitial lung disease
(ILD), (Figure 3) as a result of hemosiderosis following re-
peated blood transfusions in treating chronic anemia. This is
the ﬁrst case who had an additional ﬁnding of ILD and who
underwent a laparoscopic splenectomy. We would be dwell-
ing on the probable theories of their coexistence on the basis
of pathogenesis and ﬁnally introducing our own model of
anesthetic management of this solitary case in the literature.
2.CaseDescription
A10-year-oldgirldiagnosedasacaseofhereditaryspherocy-
tosis at the age of 1 year had an episode of convulsion at the
age of 5 years following which she developed slurred, inco-
herent, and incomprehensible speech, myoclonic move-
ments, and left sided hemiparesis. Following her hemorrha-
gic stroke, she had been receiving aspirin and warfarin. Dur-
ing the course of her illness, she had been receiving blood
transfusion oﬀ and on as a result of decrement in hemo-
globinlevels.Anosmoticfragilitytesthadbeenperformedby
placing the patient’s red blood cells in a saline solution for 24
hours.Comparedtonormalcells,thepatient’sredbloodcells
had burst sooner, establishing the diagnosis of hereditary
spherocytosis once again prior to undertaking the scheduled
laparoscopic splenectomy. A cerebral angiography (Figure 1)
depicts the classical appearance of moyamoya disease as had
been narrated in the past, with hypertrophied meningeal
arteries reﬂecting retrograde feeding (Figure 2).
The patient was scheduled for laparoscopic splenec-
tomy. On general examination, the patient exhibited bizarre
involuntary movements of the body especially evident in the2 Case Reports in Anesthesiology
Figure 1: Stenosis of both internal carotid arteries and collateral
network signifying moyamoya appearance.
Figure 2: Hypertrophy of leptomeningeal arteries with retrograde
cortical feeding.
cervicoscapular regions and the limbs coupled with facial
grimaces, undeﬁned smiles, and behavior reﬂecting gross
mental retardation. The chest X-ray and CT scan favored
an acute lung injury pattern (Figure 3) although the oxygen
saturation on breathing room air was 97%. On auscultation,
the lungs were clear and an echocardiographic report of the
heart had been normal.
After adjusting routine monitors, the patient received
preinduction fentanyl and midazolam in 50micg and 1mg
dosages, respectively. Induction was performed with thio-
pental sodium 5mg/kg, and a noncuﬀed 6.5 size ID endotra-
chealtube wasintroduced after atracurium0.5mg/kg. Remi-
fentanilandpropofolinfusionswereusedformaintenanceof
anesthesia. During the operation, phenobarbital 75mg and
hydrocortisone 30mg were given. The patient received
2L/min oxygen during the operation which lasted 3 hours.
Theendtidalcarbon-dioxidelevelwasmaintainedwithinthe
range of 35–40mmHg. The anesthetic course was unevent-
ful, and the patient was extubated and transferred to the
ward after a 30min followup in the postanesthesia care unit.
Penicillin G 100,000 units/kg was started postoperatively and
repeated every 4h. On the 5th postoperatively day, the pa-
tient was discharged and asked to report for followups.
Figure 3: A chest radiograph showing interstitial lung disease.
3. Discussion
Three cases of moyamoya syndrome and its association with
hereditary spherocytosis have so far been reported [3–5].
Since our case is the fourth one with such an association, the
foremost question that arises in one’s mind is if this associa-
tionofmoyamoyadiseaseandhereditaryspherocytosiscould
be anincidental ﬁnding orthis coincidence couldbe explain-
able on deﬁnite physiopathological grounds. Since four cases
of such an association have so far been introduced, this asso-
ciation could not perhaps be a mere coincidence, but in all
probability, the hereditary spherocytosis could perhaps have
contributed to the genesis of moyamoya disease on the assu-
mption that chronic hypoxia secondary to hemolysis of the
spherocytescouldbeactingasaprecipitatingcauseofoxygen
decrement in the brain of these patients with a possible gene-
tic predisposition, thus leading to sprouting of collaterals to
compensate for oxygen deprivation. A hypothesis somehow
resembling this one had been expressed in the past [6], but
lackofevidencefailedtoestablishit.Furtherepidemiological
reports could perhaps establish the cause and eﬀect rela-
tionship. Our case had an added ﬁnding of ILD not so far
reported in the literature. As most of these patients undergo
splenectomy at around 5yr of age, ILD has never been re-
ported.Thispatientunderwentsplenectomyatalateragebe-
cause of parent’s refusal for surgery, and repeated blood
transfusions during this time lag could most probably have
led to hemosiderosis and ILD.
In our patient, a laparoscopic splenectomy was perform-
ed where in the intra-abdominal pressure was maintained
around 10–12mmHg. The carbon-dioxide insuﬄation was
perhaps helpful, as the end tidal PaCO2 could be main-
tained above 30mmHg. Hypocapnia is preferably avoided in
patients with moyamoya disease, because the ensuring cere-
bral vasoconstriction could further decrease the already
compromisedcerebralbloodﬂow.Inouranestheticmanage-
ment, we maintained adequate hydration of the patient pre-
suming that dehydration would trigger the process of stasis
and its attendant complications.
Halothane has been used with success [7] owing to the
long-held assumption that halothane produces lesser
amount of coughing and breath holding [8], but the fact is
that it does produce them and that little amount in itself
could be deleterious for a patient with moyamoya disease
whose cerebrovascular compliance is already compromised,Case Reports in Anesthesiology 3
thus making these patients especially vulnerable to develop-
ing intraoperative ischemic episodes. Again, Suriano et al.
[7] chose isoﬂurane as part of their maintenance anesthesia
on the grounds that it had cerebral protective eﬀects during
transient cerebral ischemia in adults undergoing carotid
endarterectomy [9]. We feel that the ﬁndings attributed to
isoﬂurane regarding cerebral protection during transient
cerebral ischemia in patients undergoing carotid end-arter-
ectomycannotbeextrapolatedtochildrenhavingmoyamoya
disease,becausethepathogenesisisdiﬀerentwithmoyamoya
disease having already ushered in a host of changes in the
intracranial arteries in the form of stenosis, total blockade,
and compensation in the form of collaterals. Under such
circumstances, it would not be prudent to choose isoﬂurane,
because like the other halogenated agents, it also can
abolish autoregulation in a dose-dependent manner besides
causing a reduction in peripheral vascular resistance and
cerebrovascular tone. Cerebral autoregulation is already
disturbed in this subset of patients, and any further distur-
bance in it could hasten the process of ischemia that already
exists,unlikecarotidendarterectomy,whereischemiaistran-
siently produced in a patient in the face of normal auto-
regulation. We avoided halogenated agents to prevent vaso-
dilatation in the normal intracranial vasculature ushering in
a steal phenomenon and thus jeopardizing the regional cere-
bral blood ﬂow that could in itself cause an intraoperative or
a postoperative infarct. The vicious cycle could also increase
the cerebral blood volume, and thus raise an unnoticed
raised intracranial pressure culminating in delayed awaken-
ing or nonawakening. We employed propofol and remifen-
tanil for maintenance of anesthesia titrated to the needs of
the patient.
While reviewing the medical records of children with
moyamoya disease as reported by Soriano et al. [7], anes-
thesia had been induced by an inhalation of a mixture of
halothane in 66% nitrous oxide and 33% oxygen. In our
opinion, an inhalational induction in children with a mean
age of 7.9yr is fraught with stakes as coughing, crying, and
breath holding can all lead to or else precipitate ischemic
events in the already perilous neurovascular anatomy, where
the normal collateral vessels are already maximally dilated
and autoregulatory responses are absent or hampered. The
blood pressure in our patient was maintained close to the
baselinevaluesonthegroundsthatdeliberateorelseinadver-
tent dangerous declines in blood pressure can cause a cere-
bral infarction [10]. Thus, adequate hydration and correct
replacement of blood loss should be our goal in order to
prevent any untoward complications that may come in the
wake of these changes especially so as most of these children
present with low preoperative hemoglobin levels.
As only few cases have been reported, a logical conclu-
sioncannotbedrawnregardingthemodusoperandiforane-
sthetic management but apparently owing to the fragile and
vulnerable neurovascular pathological pattern in moyamoya
disease and the concurrent presence of hereditary spherocy-
tosis, it appears that we use anesthetic drugs that incur the
least morbidity and mortality in this subset of population
and optimize hydration and hemoglobin levels during the
perioperative period.
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